IRS2 and Insulin resistance: Additionally, PI3K/AKT, through the dephosphorylation of Insulin Receptor Substrate 1 (IRS1) and Insulin Receptor Substrate 2 (IRS2) [197], also counteracts the development of insulin resistance [198].